Immunwork completed the A-run foundraising of 670 million! Six novel drugs have been verified
2022/03
08
TE-8105 drug development was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan
2021/04
06
【Reported by Taiwan CommonWealth Magazine】The name of novel drug, which get the largest authorization, comes from the birthday of "The father of antibodies in Taiwan"
2020/05
07
【Reported by Taiwan Global Bio Monthly】Immunwork Opening! A number of products will apply for IND from 2020
2019/09
17
Immunwork won the 2019 Outstanding Biotechnology Industry Award - Potential Benchmark Award!
2019/07
18